Clinical trial
Side Effects of Newer Antipsychotics in Older Adults
NCT00245206 · Veterans Medical Research Foundation, Other · Completed
Key facts
| NCT number | NCT00245206 |
|---|---|
| Title | Side Effects of Newer Antipsychotics in Older Adults |
| Official title | Metabolic Effects of Newer Antipsychotics in Older Patients |
| Lead sponsor | Veterans Medical Research Foundation, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Alzheimer's Disease, Dementia |
| Intervention type | Drug |
| Interventions | Aripiprazole, Olanzapine, Risperidone |
| Enrollment | 406 |
| Start date | Aug 1, 2005 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Oct 27, 2005 |
| Last update posted | Dec 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: